The coagulation markers market size is projected to be worth US$ 1.21 billion in 2023. The market is likely to surpass US$ 2.22 billion by 2033 at a CAGR of 6.3% during the forecast period. Growing surgical orthopedic procedures, such as venous thromboembolism (VTE), have resulted in a market increase. According to several studies on preoperative risk assessment, the majority of patients undergoing major orthopedic surgery would be hypercoagulable. The use of coagulation markers in the screening of VTE has proven to be quite successful in detecting coagulation activation.
Other Drivers Propelling the Demand for Coagulation Markers include:
Challenges for Companies /Manufacturers in the Coagulation Markers Market:
Opportunities in the Coagulation Markers Industry:
Latest Trends in the Coagulation Markers Market:
| Attributes | Details |
|---|---|
| Coagulation Markers Market Size (2023) | US$ 1.21 billion |
| Coagulation Markers Market Projected Size (2033) | US$ 2.22 billion |
| Value CAGR (2023 to 2033) | 6.2% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
From 2012 to 2022, the global coagulation markers market experienced a CAGR of 3.5%, reaching a market size of US$ 1.21 billion in 2023. The increased frequency of coagulation diseases such as DVT, PE, and hemophilia has been a key driver for the coagulation markers industry. Because these illnesses are associated with anomalies in blood coagulation, there is a rising demand for coagulation indicators for diagnostic and monitoring purposes.
Increasing identification and diagnosis of coagulation abnormalities has resulted from increasing awareness of these illnesses, as well as enhanced diagnostic skills. Because healthcare personnel are now better trained to diagnose coagulation abnormalities, coagulation indicators are being used for diagnostic purposes. Early identification and management can enhance patient outcomes, propelling the industry forward.
Future Forecast for Coagulation Markers Industry:
Looking ahead, the global coagulation markers industry is expected to rise at a CAGR of 6.3% from 2023 to 2033. During the forecast period, the market size is expected to reach US$ 2.22 billion.
The coagulation markers industry is expected to continue its growth trajectory from 2023 to 2033. Continuous technological improvements, such as the development of innovative assays, point-of-care testing devices, and high-throughput automated analyzers, will fuel market expansion. These developments will increase the sensitivity, accuracy, and efficiency of coagulation marker testing, resulting in improved diagnostic capabilities and simpler processes.
The rise of personalized medicine and tailored therapeutics will drive up demand for coagulation indicators. By analyzing coagulation indicators, healthcare practitioners may personalize treatment strategies based on an individual's unique coagulation profile, improving therapeutic results while reducing the risk of bleeding or thrombotic events.
| Country | The United States |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 731.3 million |
| CAGR % 2023 to End of Forecast (2033) | 7.3% |
The coagulation markers industry in the United States is expected to reach a market value of US$ 731.3 million by 2033, expanding at a CAGR of 7.3%. The United States continues to experience rapid growth in market due to increasing prevalence of coagulation disorders. The prevalence of coagulation diseases such as deep vein thrombosis (DVT), pulmonary embolism (PE), and other thrombotic illnesses has increased in the United States. As a result, there is a greater need for coagulation indicators for the early identification, diagnosis, and monitoring of these illnesses.
| Country | The United Kingdom |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 160.8 million |
| CAGR % 2023 to End of Forecast (2033) | 9.4% |
The coagulation markers industry in the United Kingdom is expected to reach a market value of US$ 160.8 million, expanding at a CAGR of 9.4% during the forecast period. The United Kingdom market is projected to experience growth owing to the rising aging population. The United Kingdom has an ageing population, with an increasing number of older people. Advanced age increases the risk of coagulation diseases such atrial fibrillation, venous thromboembolism, and stroke. Coagulation marker testing is becoming more popular as the population ages in order to determine the risk of thrombotic events and guide anticoagulant medication.
| Country | China |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 276.6 million |
| CAGR % 2023 to End of Forecast (2033) | 9.0% |
The coagulation markers industry in China is anticipated to reach a market value of US$ 276.6 million, moving at a CAGR of 9.0% during the forecast period. The coagulation markers industry in China is expected to grow prominently due to the increasing research and development. The long-term socioeconomic growth of China is being centered on scientific and technical innovation, which the Chinese government is promoting through financing, reform, and societal prestige. China's 14th five-year plan (2021-2025) is focused on pursuing innovation-driven growth and aims for research and development investment to expand by more than 7% annually over that time.
The top scientific magazine, Nature Index 2020 Annual Tables, reports that China's contribution to worldwide natural science research climbed by 15% in 2020. The country's favorable environment ensures that the advances in research production witnessed in previous years will continue.
| Country | Japan |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 127.3 million |
| CAGR % 2023 to End of Forecast (2033) | 6.6% |
The coagulation markers industry in Japan is estimated to reach a market value of US$ 127.3 million by 2033, thriving at a CAGR of 6.6%. The market in Japan is predicted to grow because of the growing demand for novel therapies. Ongoing research and development activities focusing on the development of novel coagulation markers, enhanced testing procedures, and customized assays for the Japanese population have aided market expansion. Collaborations among pharmaceutical firms, research institutes, and healthcare providers foster innovation and the development of enhanced coagulation marker testing.
| Country | South Korea |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 74.1 million |
| CAGR % 2023 to End of Forecast (2033) | 5.9% |
The coagulation markers industry in South Korea is expected to reach a market value of US$ 74.1 million, expanding at a CAGR of 5.9% during the forecast period. The market in South Korea is forecasted to witness growth due to the high healthcare expenditure. South Korea spends a lot on healthcare, and the investment in diagnostics and laboratory testing is growing. Coagulation marker tests are an essential aspect of diagnosing coagulation disorders. Coagulation markers market expansion is further aided by the availability of healthcare insurance coverage and reimbursement policies.
Principal Consultant
The D-dimer assay is expected to dominate the coagulation markers industry with a CAGR of 5.4% from 2023 to 2033. By-products of blood coagulation and breakdown, such as the D-dimer, can be detected via analysis of a blood sample. D-dimer is produced when a blood clot starts to dissolve. This explains why D-dimer test has a large market share.
When a doctor suspects that anything other than DVT or PE is the cause of the symptoms, D-dimer is extremely helpful. It is an efficient, non-invasive method to assist in ruling out irregular or excessive clotting as the underlying reason.
The plasma is expected to dominate the coagulation markers industry with a CAGR of 6.2% from 2022 to 2033.
Since plasma has a high quantity of fibrinogen, this method of detecting coagulation is frequently used. Along with other procoagulants like thrombin and factor X, fibrinogen is one of the main players in the process of blood clotting. The use of plasma as a specimen for coagulation tests is increasing as a result of this factor.
The ELISA is expected to dominate the coagulation markers industry with a CAGR of 5.4% from 2023 to 2033. The Human Coagulation Factor XII ELISA kit is intended for measuring coagulation factor XII levels in plasma. ELISA kits include recombinant monoclonal antibodies for specific and sensitive findings, as well as a single-wash technique that reduces test time to 90 minutes. The demand for ELISA kits is being driven by the shortened test time and effective outcomes.
Disseminated intravascular coagulation (DIC) is expected to dominate in the application segment with a CAGR of 6.7% from 2023 to 2033. Due to the rising incidence of cancer, it is projected that the market for diffused intravascular coagulation (DIC) would expand quickly over the forecast period. By 2040, the International Agency for Research on Cancer (IARC) projects that there will be 16.3 million cancer-related deaths and 27.5 million new cases worldwide. One of the main causes of disseminated intravascular coagulation (DIC) is cancer. Blood clotting proteins become overactive in a dangerous disorder known as diffused intravascular coagulation (DIC).
By purpose, clinical use segment is expected to continue leading the market over a CAGR of 6.0% throughout the projected timeframe. Coagulation tests have been shown to be clinically useful in the detection of cardiovascular illnesses and coagulation disorders, particularly DVT. Coagulant levels in the circulation increase dramatically in response to various illnesses, making it an important indicator for diagnosis. Because of their diagnostic usefulness, Coagulation tests are now widely used in clinical practice to guide antibiotic treatment and help clinical decision-making.
The hospitals have led the coagulation markers market as the leading end user with the CAGR of 7.4% in 2023 to 2033. Hospitals are the principal providers of acute care, serving a diverse variety of patients, including those suffering from severe chronic illnesses, coagulation problems, and other urgent circumstances. Coagulation tests are extremely useful in these conditions, assisting in the diagnosis, monitoring, and treatment of cardiovascular disorders. In these acute care circumstances, hospitals rely on coagulation tests to assist clinical decision-making, guide antibiotic treatment, and assess patient prognosis.
The coagulation markers industry is highly competitive, with numerous players vying for market share. In such a scenario, key players must adopt effective strategies to stay ahead of the competition.
Key Strategies Adopted by the Players
Companies invest heavily in research and development to deliver novel products that improve efficiency, dependability, and cost-effectiveness. Product innovation allows businesses to differentiate themselves from their competition while also catering to the changing demands of their clients.
Key industry leaders frequently develop strategic partnerships and collaborations with other companies in order to harness their strengths and increase their market reach. Companies might also gain access to new technology and markets through such agreements.
The coagulation markers sector is expanding rapidly in emerging regions such as China and India. Key firms are enhancing their distribution networks and developing local manufacturing facilities to increase their presence in these areas.
Mergers and acquisitions are frequently used by key players in the coagulation markers business to consolidate their market position, increase their product portfolio, and gain access to new markets.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key Developments in the Coagulation Markers Market:
China, India, Japan dominate the market in Asia Pacific.
The healthcare sector is the main consumer of coagulation indicators.
The United States is predicted to record a CAGR of 5% from 2023 to 2033.
The global coagulation markers market was valued at US$ 1.21 billion in 2023
The global coagulation markers market is projected to reach US$ 2.22 billion by 2033.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value Added Insights
4.1. Product Adoption/ Usage Analysis
4.2. Product USPs/ Features
4.3. Technological Roadmap
4.4. Regulatory Landscape
4.5. PESTEL Analysis
4.6. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Key Player’s Historic Growth
5.2.2. Reimbursements Policies
5.2.3. Prevalence of Coagulation Disorders
5.2.4. Increasing Preference for Better Diagnostic And Monitoring Technologies
5.2.5. Frequency of Product Approvals
5.2.6. Strategic Collaborations Among Players
5.3. Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Market Volume (in Units) Analysis 2012 to 2022 and Forecast, 2023 to 2033
6.1. Historical Volume (in Units) Analysis, 2012 to 2022
6.2. Current and Future Volume (in Units) Projections, 2023 to 2033
6.2.1. Y-o-Y Growth Trend Analysis
7. Global Market - Pricing Analysis
7.1. Regional Pricing Analysis By Product
7.2. Pricing Break-up
7.2.1. Manufacturer Level Pricing
7.2.2. Distributor Level Pricing
7.3. Global Average Pricing Analysis Benchmark
7.4. Pricing Assumptions
8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2012 to 2022 and Forecast, 2023 to 2033
8.1. Historical Market Value (US$ Million) and Volume (Units) Analysis, 2012 to 2022
8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2012 to 2022
9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2023 to 2033
9.3.1. D-dimer Assay
9.3.2. Fibrinogen Assay
9.4. Market Attractiveness Analysis By Product
10. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Sample Type
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis By Sample Type, 2012 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Sample Type, 2023 to 2033
10.3.1. Plasma
10.3.2. Whole Blood Sample
10.3.3. Other
10.4. Market Attractiveness Analysis By Sample Type
11. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Technology
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis By Technology, 2012 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Technology, 2023 to 2033
11.3.1. Fluorescence Immunoassay
11.3.2. ELISA
11.3.3. Rapid Test
11.3.4. Particle-enhanced Immunoturbidimetric Assay
11.4. Market Attractiveness Analysis By Technology
12. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Application
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) Analysis By Application, 2012 to 2022
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033
12.3.1. Deep Venous Thrombosis (DVT)
12.3.2. Pulmonary Embolism (PE)
12.3.3. Disseminated Intravascular Coagulation (DIC)
12.3.4. Trauma
12.3.5. Others
12.4. Market Attractiveness Analysis By Application
13. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Purpose
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Million) Analysis By Purpose, 2012 to 2022
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Purpose, 2023 to 2033
13.3.1. Clinical Use
13.3.2. Research Use Only
13.4. Market Attractiveness Analysis By Purpose
14. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By End User
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Million) Analysis By End User, 2012 to 2022
14.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033
14.3.1. Hospital
14.3.2. Specialty Clinics
14.3.3. Academic and Research Institutes
14.3.4. Diagnostics Laboratories
14.4. Market Attractiveness Analysis By End User
15. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by Region
15.1. Introduction
15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2012 to 2022
15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2023 to 2033
15.3.1. North America
15.3.2. Latin America
15.3.3. Europe
15.3.4. South Asia
15.3.5. East Asia
15.3.6. Oceania
15.3.7. Middle East and Africa (Middle East & Africa)
15.4. Market Attractiveness Analysis By Region
16. North America Market Analysis 2012 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022
16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. USA
16.3.1.2. Canada
16.3.2. By Product
16.3.3. By Sample Type
16.3.4. By Technology
16.3.5. By Application
16.3.6. By Purpose
16.3.7. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Sample Type
16.4.4. By Technology
16.4.5. By Application
16.4.6. By Purpose
16.4.7. By End User
16.5. Country Level Analysis & Forecast
16.5.1. USA Market Analysis
16.5.1.1. Introduction
16.5.1.2. Market Analysis and Forecast by Market Taxonomy
16.5.1.2.1. By Product
16.5.1.2.2. By Sample Type
16.5.1.2.3. By Technology
16.5.1.2.4. By Application
16.5.1.2.5. By Purpose
16.5.1.2.6. By End User
16.5.2. Canada Market Analysis
16.5.2.1. Introduction
16.5.2.2. Market Analysis and Forecast by Market Taxonomy
16.5.2.2.1. By Product
16.5.2.2.2. By Sample Type
16.5.2.2.3. By Technology
16.5.2.2.4. By Application
16.5.2.2.5. By Purpose
16.5.2.2.6. By End User
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
17. Latin America Market Analysis 2012 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022
17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. Brazil
17.3.1.2. Mexico
17.3.1.3. Argentina
17.3.1.4. Rest of Latin America
17.3.2. By Product
17.3.3. By Sample Type
17.3.4. By Technology
17.3.5. By Application
17.3.6. By Purpose
17.3.7. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Sample Type
17.4.4. By Technology
17.4.5. By Application
17.4.6. By Purpose
17.4.7. By End User
17.5. Country Level Analysis & Forecast
17.5.1. Brazil Market Analysis
17.5.1.1. Introduction
17.5.1.2. Market Analysis and Forecast by Market Taxonomy
17.5.1.2.1. By Product
17.5.1.2.2. By Sample Type
17.5.1.2.3. By Technology
17.5.1.2.4. By Application
17.5.1.2.5. By Purpose
17.5.1.2.6. By End User
17.5.2. Mexico Market Analysis
17.5.2.1. Introduction
17.5.2.2. Market Analysis and Forecast by Market Taxonomy
17.5.2.2.1. By Product
17.5.2.2.2. By Sample Type
17.5.2.2.3. By Technology
17.5.2.2.4. By Application
17.5.2.2.5. By Purpose
17.5.2.2.6. By End User
17.5.3. Argentina Market Analysis
17.5.3.1. Introduction
17.5.3.2. Market Analysis and Forecast by Market Taxonomy
17.5.3.2.1. By Product
17.5.3.2.2. By Sample Type
17.5.3.2.3. By Technology
17.5.3.2.4. By Application
17.5.3.2.5. By Purpose
17.5.3.2.6. By End User
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
18. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022
18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
18.3.1. By Country
18.3.1.1. Germany
18.3.1.2. France
18.3.1.3. Italy
18.3.1.4. UK
18.3.1.5. Spain
18.3.1.6. Russia
18.3.1.7. BENELUX
18.3.1.8. Rest of Europe
18.3.2. By Product
18.3.3. By Sample Type
18.3.4. By Technology
18.3.5. By Application
18.3.6. By Purpose
18.3.7. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Sample Type
18.4.4. By Technology
18.4.5. By Application
18.4.6. By Purpose
18.4.7. By End User
18.5. Country Level Analysis & Forecast
18.5.1. Germany Market Analysis
18.5.1.1. Introduction
18.5.1.2. Market Analysis and Forecast by Market Taxonomy
18.5.1.2.1. By Product
18.5.1.2.2. By Sample Type
18.5.1.2.3. By Technology
18.5.1.2.4. By Application
18.5.1.2.5. By Purpose
18.5.1.2.6. By End User
18.5.2. France Market Analysis
18.5.2.1. Introduction
18.5.2.2. Market Analysis and Forecast by Market Taxonomy
18.5.2.2.1. By Product
18.5.2.2.2. By Sample Type
18.5.2.2.3. By Technology
18.5.2.2.4. By Application
18.5.2.2.5. By Purpose
18.5.2.2.6. By End User
18.5.3. Italy Market Analysis
18.5.3.1. Introduction
18.5.3.2. Market Analysis and Forecast by Market Taxonomy
18.5.3.2.1. By Product
18.5.3.2.2. By Sample Type By Technology
18.5.3.2.3. By Application
18.5.3.2.4. By Purpose
18.5.3.2.5. By End User
18.5.4. UK Market Analysis
18.5.4.1. Introduction
18.5.4.2. Market Analysis and Forecast by Market Taxonomy
18.5.4.2.1. By Product
18.5.4.2.2. By Sample Type
18.5.4.2.3. By Technology
18.5.4.2.4. By Application
18.5.4.2.5. By Purpose
18.5.4.2.6. By End User
18.5.5. Spain Market Analysis
18.5.5.1. Introduction
18.5.5.2. Market Analysis and Forecast by Market Taxonomy
18.5.5.2.1. By Product
18.5.5.2.2. By Sample Type
18.5.5.2.3. By Technology
18.5.5.2.4. By Application
18.5.5.2.5. By Purpose
18.5.5.2.6. By End User
18.5.6. Russia Market Analysis
18.5.6.1. Introduction
18.5.6.2. Market Analysis and Forecast by Market Taxonomy
18.5.6.2.1. By Product
18.5.6.2.2. By Sample Type
18.5.6.2.3. By Technology
18.5.6.2.4. By Application
18.5.6.2.5. By Purpose
18.5.6.2.6. By End User
18.5.7. BENELUX Market Analysis
18.5.7.1. Introduction
18.5.7.2. Market Analysis and Forecast by Market Taxonomy
18.5.7.2.1. By Product
18.5.7.2.2. By Sample Type
18.5.7.2.3. By Technology
18.5.7.2.4. By Application
18.5.7.2.5. By Purpose
18.5.7.2.6. By End User
18.6. Market Trends
18.7. Key Market Participants - Intensity Mapping
18.8. Drivers and Restraints - Impact Analysis
19. South Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033
19.1. Introduction
19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022
19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
19.3.1. By Country
19.3.1.1. India
19.3.1.2. Thailand
19.3.1.3. Indonesia
19.3.1.4. Malaysia
19.3.1.5. Rest of South Asia
19.3.2. By Product
19.3.3. By Sample Type
19.3.4. By Technology
19.3.5. By Application
19.3.6. By Purpose
19.3.7. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Sample Type
19.4.4. By Technology
19.4.5. By Application
19.4.6. By Purpose
19.4.7. By End User
19.5. Country Level Analysis & Forecast
19.5.1. India Market Analysis
19.5.1.1. Introduction
19.5.1.2. Market Analysis and Forecast by Market Taxonomy
19.5.1.2.1. By Product
19.5.1.2.2. By Sample Type
19.5.1.2.3. By Technology
19.5.1.2.4. By Application
19.5.1.2.5. By Purpose
19.5.1.2.6. By End User
19.5.2. Thailand Market Analysis
19.5.2.1. Introduction
19.5.2.2. Market Analysis and Forecast by Market Taxonomy
19.5.2.2.1. By Product
19.5.2.2.2. By Sample Type
19.5.2.2.3. By Technology
19.5.2.2.4. By Application
19.5.2.2.5. By Purpose
19.5.2.2.6. By End User
19.5.3. Indonesia Market Analysis
19.5.3.1. Introduction
19.5.3.2. Market Analysis and Forecast by Market Taxonomy
19.5.3.2.1. By Product
19.5.3.2.2. By Sample Type
19.5.3.2.3. By Technology
19.5.3.2.4. By Application
19.5.3.2.5. By Purpose
19.5.3.2.6. By End User
19.5.4. Malaysia Market Analysis
19.5.4.1. Introduction
19.5.4.2. Market Analysis and Forecast by Market Taxonomy
19.5.4.2.1. By Product
19.5.4.2.2. By Sample Type
19.5.4.2.3. By Technology
19.5.4.2.4. By Application
19.5.4.2.5. By Purpose
19.5.4.2.6. By End User
19.6. Market Trends
19.7. Key Market Participants - Intensity Mapping
19.8. Drivers and Restraints - Impact Analysis
20. East Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033
20.1. Introduction
20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022
20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
20.3.1. By Country
20.3.1.1. China
20.3.1.2. Japan
20.3.1.3. South Korea
20.3.2. By Product
20.3.3. By Sample Type
20.3.4. By Technology
20.3.5. By Application
20.3.6. By Purpose
20.3.7. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Product
20.4.3. By Sample Type
20.4.4. By Technology
20.4.5. By Application
20.4.6. By Purpose
20.4.7. By End User
20.5. Country Level Analysis & Forecast
20.5.1. China Market Analysis
20.5.1.1. Introduction
20.5.1.2. Market Analysis and Forecast by Market Taxonomy
20.5.1.2.1. By Product
20.5.1.2.2. By Sample Type
20.5.1.2.3. By Technology
20.5.1.2.4. By Application
20.5.1.2.5. By Purpose
20.5.1.2.6. By End User
20.5.2. Japan Market Analysis
20.5.2.1. Introduction
20.5.2.2. Market Analysis and Forecast by Market Taxonomy
20.5.2.2.1. By Product
20.5.2.2.2. By Sample Type
20.5.2.2.3. By Technology
20.5.2.2.4. By Application
20.5.2.2.5. By Purpose
20.5.2.2.6. By End User
20.5.3. South Korea Market Analysis
20.5.3.1. Introduction
20.5.3.2. Market Analysis and Forecast by Market Taxonomy
20.5.3.2.1. By Product
20.5.3.2.2. By Sample Type
20.5.3.2.3. By Technology
20.5.3.2.4. By Application
20.5.3.2.5. By Purpose
20.5.3.2.6. By End User
20.6. Market Trends
20.7. Key Market Participants - Intensity Mapping
20.8. Drivers and Restraints - Impact Analysis
21. Oceania Market Analysis 2012 to 2022 and Forecast 2023 to 2033
21.1. Introduction
21.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022
21.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
21.3.1. By Country
21.3.1.1. Australia
21.3.1.2. New Zealand
21.3.2. By Product
21.3.3. By Sample Type
21.3.4. By Technology
21.3.5. By Application
21.3.6. By Purpose
21.3.7. By End User
21.4. Market Attractiveness Analysis
21.4.1. By Country
21.4.2. By Product
21.4.3. By Sample Type
21.4.4. By Technology
21.4.5. By Application
21.4.6. By Purpose
21.4.7. By End User
21.5. Country Level Analysis & Forecast
21.5.1. Australia Market Analysis
21.5.1.1. Introduction
21.5.1.2. Market Analysis and Forecast by Market Taxonomy
21.5.1.2.1. By Product
21.5.1.2.2. By Sample Type
21.5.1.2.3. By Technology
21.5.1.2.4. By Application
21.5.1.2.5. By Purpose
21.5.1.2.6. By End User
21.5.2. New Zealand Market Analysis
21.5.2.1. Introduction
21.5.2.2. Market Analysis and Forecast by Market Taxonomy
21.5.2.2.1. By Product
21.5.2.2.2. By Sample Type
21.5.2.2.3. By Technology
21.5.2.2.4. By Application
21.5.2.2.5. By Purpose
21.5.2.2.6. By End User
21.6. Market Trends
21.7. Key Market Participants - Intensity Mapping
21.8. Drivers and Restraints - Impact Analysis
22. Middle East and Africa Market Analysis 2012 to 2022 and Forecast 2023 to 2033
22.1. Introduction
22.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022
22.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
22.3.1. By Country
22.3.1.1. GCC Countries
22.3.1.2. Türkiye
22.3.1.3. Northern Africa
22.3.1.4. South Africa
22.3.1.5. Rest of Middle East and Africa
22.3.2. By Product
22.3.3. By Sample Type
22.3.4. By Technology
22.3.5. By Application
22.3.6. By Purpose
22.3.7. By End User
22.4. Market Attractiveness Analysis
22.4.1. By Country
22.4.2. By Product
22.4.3. By Sample Type
22.4.4. By Technology
22.4.5. By Application
22.4.6. By Purpose
22.4.7. By End User
22.5. Country Level Analysis & Forecast
22.5.1. GCC Countries Market Analysis
22.5.1.1. Introduction
22.5.1.2. Market Analysis and Forecast by Market Taxonomy
22.5.1.2.1. By Product
22.5.1.2.2. By Sample Type
22.5.1.2.3. By Technology
22.5.1.2.4. By Application
22.5.1.2.5. By Purpose
22.5.1.2.6. By End User
22.5.2. Türkiye Market Analysis
22.5.2.1. Introduction
22.5.2.2. Market Analysis and Forecast by Market Taxonomy
22.5.2.2.1. By Product
22.5.2.2.2. By Sample Type
22.5.2.2.3. By Technology
22.5.2.2.4. By Application
22.5.2.2.5. By Purpose
22.5.2.2.6. By End User
22.5.3. Northern Africa Market Analysis
22.5.3.1. Introduction
22.5.3.2. Market Analysis and Forecast by Market Taxonomy
22.5.3.2.1. By Product
22.5.3.2.2. By Sample Type
22.5.3.2.3. By Technology
22.5.3.2.4. By Application
22.5.3.2.5. By Purpose
22.5.3.2.6. By End User
22.5.4. South Africa Market Analysis
22.5.4.1. Introduction
22.5.4.2. Market Analysis and Forecast by Market Taxonomy
22.5.4.2.1. By Product
22.5.4.2.2. By Sample Type
22.5.4.2.3. By Technology
22.5.4.2.4. By Application
22.5.4.2.5. By Purpose
22.5.4.2.6. By End User
22.6. Market Trends
22.7. Key Market Participants - Intensity Mapping
22.8. Drivers and Restraints - Impact Analysis
23. Market Structure Analysis
23.1. Market Analysis by Tier of Companies
23.2. Market Share Analysis of Top Players
23.3. Market Presence Analysis
24. Competition Analysis
24.1. Competition Dashboard
24.2. Branding and Promotional Strategies, By Key Players
24.3. Key Development Analysis
24.4. Competition Deep Dive
24.4.1. Accuquik Test Kits
24.4.1.1. Overview
24.4.1.2. Product Portfolio
24.4.1.3. Key Financials
24.4.1.4. Sales Footprint
24.4.1.5. SWOT Analysis
24.4.1.6. Strategy Overview
24.4.1.6.1. Marketing Strategy
24.4.1.6.2. Product Strategy
24.4.1.6.3. Channel Strategy
24.4.2. CTK Biotech, Inc.
24.4.2.1. Overview
24.4.2.2. Product Portfolio
24.4.2.3. Key Financials
24.4.2.4. Sales Footprint
24.4.2.5. SWOT Analysis
24.4.2.6. Strategy Overview
24.4.2.6.1. Marketing Strategy
24.4.2.6.2. Product Strategy
24.4.2.6.3. Channel Strategy
24.4.3. Siemens Healthcare Private Limited
24.4.3.1. Overview
24.4.3.2. Product Portfolio
24.4.3.3. Key Financials
24.4.3.4. Sales Footprint
24.4.3.5. SWOT Analysis
24.4.3.6. Strategy Overview
24.4.3.6.1. Marketing Strategy
24.4.3.6.2. Product Strategy
24.4.3.6.3. Channel Strategy
24.4.4. Quidel Corporation
24.4.4.1. Overview
24.4.4.2. Product Portfolio
24.4.4.3. Key Financials
24.4.4.4. Sales Footprint
24.4.4.5. SWOT Analysis
24.4.4.6. Strategy Overview
24.4.4.6.1. Marketing Strategy
24.4.4.6.2. Product Strategy
24.4.4.6.3. Channel Strategy
24.4.5. Eurolyser Diagnostica GmbH
24.4.5.1. Overview
24.4.5.2. Product Portfolio
24.4.5.3. Key Financials
24.4.5.4. Sales Footprint
24.4.5.5. SWOT Analysis
24.4.5.6. Strategy Overview
24.4.5.6.1. Marketing Strategy
24.4.5.6.2. Product Strategy
24.4.5.6.3. Channel Strategy
24.4.6. Goldsite Diagnostics Inc
24.4.6.1. Overview
24.4.6.2. Product Portfolio
24.4.6.3. Key Financials
24.4.6.4. Sales Footprint
24.4.6.5. SWOT Analysis
24.4.6.6. Strategy Overview
24.4.6.6.1. Marketing Strategy
24.4.6.6.2. Product Strategy
24.4.6.6.3. Channel Strategy
24.4.7. Diazyme Laboratories, Inc
24.4.7.1. Overview
24.4.7.2. Product Portfolio
24.4.7.3. Key Financials
24.4.7.4. Sales Footprint
24.4.7.5. SWOT Analysis
24.4.7.6. Strategy Overview
24.4.7.6.1. Marketing Strategy
24.4.7.6.2. Product Strategy
24.4.7.6.3. Channel Strategy
24.4.8. Hipro Biotechnology Co.,Ltd.
24.4.8.1. Overview
24.4.8.2. Product Portfolio
24.4.8.3. Key Financials
24.4.8.4. Sales Footprint
24.4.8.5. SWOT Analysis
24.4.8.6. Strategy Overview
24.4.8.6.1. Marketing Strategy
24.4.8.6.2. Product Strategy
24.4.8.6.3. Channel Strategy
25. Assumptions and Acronyms Used
26. Research Methodology
Explore Healthcare Insights
View Reports
Coagulation Markers Market
